Market Research Report
North America 3D Cell Culture Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||910168|
|Published||Content info||120 Pages
Delivery time: 2-3 business days
|North America 3D Cell Culture Market Forecast 2019-2027|
|Published: September 6, 2019||Content info: 120 Pages||
The North America 3D cell culture market is expected to grow at a CAGR of 11.85% during the forecast period. The technological advancements, rising demand for 3D cell culture, market expansion, the increasing incidence rates, infrastructural developments, etc. are estimated to be the factors influencing the growth of the market.
The North America 3D cell culture market is determined on the basis of the United States and Canada market regions. The United States market is estimated to grow owing to the healthcare expenditure with regard to prevailing chronic diseases. The increasing adoption of 3D cellular models and its resulting advantages drives the growth of the US market. The active presence of molecular R&D laboratories and the involvement of companies in the research are driving the Canadian market. 3D culture methods require expertise and competence in handling and optimization. Moreover, the standard cell analysis methods used for the 3D cultures was originally designed for 2D cultures, which pose a challenge for the function and growth of the market in the region.
Thermo Fisher Scientific, Inc., Nano3D Biosciences, VWR International LLC, GE Healthcare, Emulate, etc. are some of the prominent companies in the 3D cell culture market. The companies follow various corporate strategies to maintain a stronghold in the market.